Emergent BioSolutions (EBS) Interest & Investment Income: 2010-2018
Historic Interest & Investment Income for Emergent BioSolutions (EBS) over the last 9 years, with Sep 2018 value amounting to $701,000.
- Emergent BioSolutions' Interest & Investment Income rose 10.05% to $701,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $1.4 million, marking a year-over-year decrease of 26.20%. This contributed to the annual value of $1.8 million for FY2017, which is 66.48% up from last year.
- Emergent BioSolutions' Interest & Investment Income amounted to $701,000 in Q3 2018, which was up 129.08% from $306,000 recorded in Q2 2018.
- Over the past 5 years, Emergent BioSolutions' Interest & Investment Income peaked at $701,000 during Q3 2018, and registered a low of $31,000 during Q2 2014.
- For the 3-year period, Emergent BioSolutions' Interest & Investment Income averaged around $366,727, with its median value being $306,000 (2018).
- In the last 5 years, Emergent BioSolutions' Interest & Investment Income skyrocketed by 955.56% in 2014 and then tumbled by 47.51% in 2018.
- Quarterly analysis of 5 years shows Emergent BioSolutions' Interest & Investment Income stood at $190,000 in 2014, then plummeted by 40.53% to $113,000 in 2015, then spiked by 155.75% to $289,000 in 2016, then slumped by 44.64% to $160,000 in 2017, then increased by 10.05% to $701,000 in 2018.
- Its Interest & Investment Income was $701,000 in Q3 2018, compared to $306,000 in Q2 2018 and $222,000 in Q1 2018.